10-Q Filing

TYME TECHNOLOGIES, INC. CIK: 1537917 Q3 2019

Filing Information

Form Type	10-Q
Accession Number	`0001564590-19-002477`
Period End Date	20181231
Filing Date	20190211
Fiscal Year	2019
Fiscal Period	Q3
XBRL Instance	tyme-20181231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 57 Income Statement 41 Cash Flow Statement 42 Stockholders Equity 16

Balance Sheet 57 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$16.73M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.81M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.48M	USD	Point-in-time
Prepaid rent	`PrepaidRent`	$242.75K	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$510.35K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$286.72K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$732.55K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$17.77M	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$29.71M	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Property and equipment, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$3.24K	USD	Point-in-time
Property and equipment, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$11.68K	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsNoncurrent`	$1.27M	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsNoncurrent`	$1.31M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid rent, net of current portion	`PrepaidRentNoncurrent`	$161.84K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Total assets	`Assets`	$19.21M	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Total assets	`Assets`	$31.02M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	101.23M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	103.19M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	103.19M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	101.23M	shares	Point-in-time
Accounts payable and other current liabilities (including $181,000 and $384,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$2.82M	USD	Point-in-time
Accounts payable and other current liabilities (including $181,000 and $384,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$2.30M	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.25M	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.17M	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$39.02K	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$480.09K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.55M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.50M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.55M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.50M	USD	Point-in-time
Commitments and contingencies (see Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (see Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 103,190,385 and 101,226,479 issued and outstanding at December 31, 2018 and March 31, 2018, respectively	`CommonStockValue`	$10.32K	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 103,190,385 and 101,226,479 issued and outstanding at December 31, 2018 and March 31, 2018, respectively	`CommonStockValue`	$10.12K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$79.29M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$90.32M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-52.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-74.62M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.71M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$26.47M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$19.21M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$31.02M	USD	Point-in-time

Income Statement 41 line items

Line Item	Tag	Value	Unit	Period
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$588.00K	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	3 Qtrs
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$132.00K	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$1.56M	USD	3 Qtrs
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$794.00K	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.53M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$6.40M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$10.98M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.59M	USD	1 Quarter
General and administrative (including $132,000, $588,000, $794,000 and $1,559,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$2.98M	USD	1 Quarter
General and administrative (including $132,000, $588,000, $794,000 and $1,559,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$10.83M	USD	3 Qtrs
General and administrative (including $132,000, $588,000, $794,000 and $1,559,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$7.64M	USD	3 Qtrs
General and administrative (including $132,000, $588,000, $794,000 and $1,559,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.55M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$21.81M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$5.56M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$8.08M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$14.05M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.56M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-8.08M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-21.81M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-14.05M	USD	3 Qtrs
Other income	`NonoperatingIncomeExpense`	$28.72K	USD	3 Qtrs
Other income	`NonoperatingIncomeExpense`	$28.72K	USD	1 Quarter
Other income	`NonoperatingIncomeExpense`	$390.38K	USD	3 Qtrs
Interest expense	`InterestExpense`	$7.28K	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.22K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-13.66M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-21.79M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-8.05M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.56M	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.15	USD	3 Qtrs
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.21	USD	3 Qtrs
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	103.01M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.93M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.50M	shares	3 Qtrs
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	101.96M	shares	3 Qtrs

Cash Flow Statement 42 line items

Line Item	Tag	Value	Unit	Period
Cashless exercise of warrants	`CashlessExerciseOfWarrants`	301,959.00	shares	3 Qtrs
Net loss	`ProfitLoss`	$-21.79M	USD	3 Qtrs
Cashless exercise of shares of common stock	`CashlessExerciseOfSharesOfCommonStock`	84,034.00	shares	3 Qtrs
Net loss	`ProfitLoss`	$-13.66M	USD	3 Qtrs
Depreciation	`Depreciation`	$7.11K	USD	3 Qtrs
Depreciation	`Depreciation`	$3.22K	USD	3 Qtrs
Amortization of employees, directors and consultants stock options	`AmortizationOfEmployeesDirectorsAndConsultantsStockOptions`	$6.64M	USD	3 Qtrs
Amortization of employees, directors and consultants stock options	`AmortizationOfEmployeesDirectorsAndConsultantsStockOptions`	$6.70M	USD	3 Qtrs
Gain on remeasurement of derivative liability	`DerivativeGainLossOnDerivativeNet`	$390.38K	USD	3 Qtrs
Prepaid rent	`IncreaseDecreaseInPrepaidRent`	$404.59K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-445.83K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.57M	USD	3 Qtrs
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$470.15K	USD	3 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$765.37K	USD	3 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-521.84K	USD	3 Qtrs
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-80.90K	USD	3 Qtrs
Net cash used in operating expenses	`NetCashProvidedByUsedInOperatingActivities`	$-5.20M	USD	1 Quarter
Net cash used in operating expenses	`NetCashProvidedByUsedInOperatingActivities`	$-16.11M	USD	3 Qtrs
Net cash used in operating expenses	`NetCashProvidedByUsedInOperatingActivities`	$-8.20M	USD	3 Qtrs
Purchase of property & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.54K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-15.54K	USD	3 Qtrs
Insurance note payments	`InsuranceNotePayments`	$441.08K	USD	3 Qtrs
Proceeds from private placement offering of common stock and warrants, net of issuance costs	`ProceedsFromIssuanceOfPrivatePlacement`	$2.60M	USD	3 Qtrs
Issuance of common stock from at-the-market financing	`ProceedsFromIssuanceOfCommonStock`	$5.75M	USD	3 Qtrs
Issuance of common stock from at-the-market financing	`ProceedsFromIssuanceOfCommonStock`	$4.05M	USD	3 Qtrs
Issuance of common stock from at-the-market financing	`ProceedsFromIssuanceOfCommonStock`	$32.10M	USD	Annual
Proceeds from collection of stock subscription receivable	`ProceedsFromCollectionOfStockSubscriptionReceivable`	$175.00K	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$270.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.88M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$8.53M	USD	3 Qtrs
Net (decrease)increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$322.80K	USD	3 Qtrs
Net (decrease)increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-12.24M	USD	3 Qtrs
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$16.73M	USD	Point-in-time
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$10.81M	USD	Point-in-time
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$10.48M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$16.73M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$10.81M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$10.48M	USD	Point-in-time
Interest	`InterestPaidNet`	$7.28K	USD	3 Qtrs
Derivative liability associated with the price protection feature of shares of common stock issued	`NonCashFairValueofDerivativeLiability`	$11.79K	USD	3 Qtrs

Stockholders Equity 16 line items

Line Item	Tag	Value	Unit	Period
Balance, at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.47M	USD	Point-in-time
Balance, at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.71M	USD	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	103.19M	shares	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	101.23M	shares	Point-in-time
Issuance of common stock from at-the-market financing facility, net of associated expenses	`StockIssuedDuringPeriodValueNewIssues`	$4.05M	USD	3 Qtrs
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$270.00K	USD	3 Qtrs
Exercise of options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	100,000.00	shares	3 Qtrs
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$6.70M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-13.66M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-21.79M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-8.05M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.56M	USD	1 Quarter
Balance, at end	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.47M	USD	Point-in-time
Balance, at end	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.71M	USD	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	103.19M	shares	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	101.23M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.